[go: up one dir, main page]

DE60028593D1 - Perkutane absorptionsbeschleuniger für die elektroporation - Google Patents

Perkutane absorptionsbeschleuniger für die elektroporation

Info

Publication number
DE60028593D1
DE60028593D1 DE60028593T DE60028593T DE60028593D1 DE 60028593 D1 DE60028593 D1 DE 60028593D1 DE 60028593 T DE60028593 T DE 60028593T DE 60028593 T DE60028593 T DE 60028593T DE 60028593 D1 DE60028593 D1 DE 60028593D1
Authority
DE
Germany
Prior art keywords
electroporation
percutanean
absorption accelerator
percutaneous
sorbefacients
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60028593T
Other languages
English (en)
Other versions
DE60028593T2 (de
Inventor
Yoshihiro Tokudome
Koji Owaku
Kenichi Goto
Kenji Sugibayashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pola Orbis Holdings Inc
Original Assignee
Pola Chemical Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pola Chemical Industries Inc filed Critical Pola Chemical Industries Inc
Publication of DE60028593D1 publication Critical patent/DE60028593D1/de
Application granted granted Critical
Publication of DE60028593T2 publication Critical patent/DE60028593T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE60028593T 1999-10-15 2000-04-06 Perkutane absorptionsbeschleuniger für die elektroporation Expired - Fee Related DE60028593T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP29324099 1999-10-15
JP29324099 1999-10-15
PCT/JP2000/002244 WO2001026688A1 (fr) 1999-10-15 2000-04-06 Promoteurs d'absorption percutanee pour electroporation

Publications (2)

Publication Number Publication Date
DE60028593D1 true DE60028593D1 (de) 2006-07-20
DE60028593T2 DE60028593T2 (de) 2007-01-25

Family

ID=17792260

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60028593T Expired - Fee Related DE60028593T2 (de) 1999-10-15 2000-04-06 Perkutane absorptionsbeschleuniger für die elektroporation

Country Status (8)

Country Link
US (1) US6721595B1 (de)
EP (1) EP1222931B1 (de)
JP (1) JP4871469B2 (de)
AT (1) ATE328581T1 (de)
AU (1) AU3672100A (de)
CA (1) CA2387370C (de)
DE (1) DE60028593T2 (de)
WO (1) WO2001026688A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1938012A (zh) * 2004-03-31 2007-03-28 兴和株式会社 外用剂
US20080299182A1 (en) * 2007-03-01 2008-12-04 Shuyuan Zhang Methods and formulations for topical gene therapy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989006555A1 (en) * 1988-01-21 1989-07-27 Massachusetts Institute Of Technology Transport of molecules across tissue using electroporation
US5240932A (en) * 1990-03-30 1993-08-31 Yasunori Morimoto Percutaneously absorbable compositions of morphine or analogous analgesics of morphine
JPH0616538A (ja) * 1992-07-03 1994-01-25 Japan Tobacco Inc イオントフォレーゼのための薬物吸収用液組成物
JP3908795B2 (ja) * 1994-11-29 2007-04-25 久光製薬株式会社 ケトチフェン含有経皮投与製剤
US5990179A (en) 1995-04-28 1999-11-23 Alza Corporation Composition and method of enhancing electrotransport agent delivery
JP3898250B2 (ja) * 1996-03-26 2007-03-28 久光製薬株式会社 エレクトロポレーション用マイクロエマルション製剤
WO1999065563A1 (en) * 1998-06-19 1999-12-23 Genetronics, Inc. Electrically assisted transdermal method and apparatus for the treatment of erectile dysfunction
WO2000023099A1 (en) * 1998-10-16 2000-04-27 Novo Nordisk A/S Insulin preparations for pulmonary delivery containing menthol
US7089053B1 (en) * 1999-10-14 2006-08-08 Pola Chemical Industries Inc Compositions for drug administration by electroporation

Also Published As

Publication number Publication date
EP1222931A4 (de) 2005-03-23
WO2001026688A1 (fr) 2001-04-19
US6721595B1 (en) 2004-04-13
JP4871469B2 (ja) 2012-02-08
CA2387370A1 (en) 2001-04-19
EP1222931B1 (de) 2006-06-07
ATE328581T1 (de) 2006-06-15
AU3672100A (en) 2001-04-23
DE60028593T2 (de) 2007-01-25
EP1222931A1 (de) 2002-07-17
CA2387370C (en) 2008-12-23

Similar Documents

Publication Publication Date Title
HN1998000143A (es) Tetrahidronaftalenos substituidos y compuestos analogos.
AU7779900A (en) Trifluoromethyl-substituted spirocyclic ketoenols
BR0210519A (pt) Composições farmacêuticas de adsorvatos de fármaco amorfo
EP2505207A3 (de) Modifizierte Exendine und Anwendungen davon
BR0311762A (pt) Beneficiador de cetano orgânico
PL1841743T3 (pl) Amidy kwasu 3-arylo-3-hydroksy-2-aminopropionowego, amidy kwasu 3-heteroarylo-3-hydroksy-2-aminopropionowego i powiązane związki o działaniu przeciwbólowym i/lub immunostymulacyjnym
GEP20074210B (en) Tropane derivatives as ccr5 modulators
PT1017659E (pt) Tetra-hidronaftalenos substituidos e compostos analogos
ATE325789T1 (de) Aminocyclohexylether-verbindungen und deren verwendung
DE502004002571D1 (de) Substituierte 3-pyrrolidin-indol-derivate
DE50004443D1 (de) Wirkstoffhaltige komposition sowie deren herstellung und verwendung
AU2003273869A1 (en) Stable polyurethane systems
DE60113445D1 (de) Substanzen mit verzweigten linkermolekülen
ES2113636T3 (es) Trioles sustituidos.
DE60031709D1 (de) Zusammensetzungen für die elektroporation
SE0301320D0 (sv) Positive modulators of nicotinic acetylcholine receptors
WO2002030357A3 (en) Compounds and methods for modulating ccr4 function
DE69924304D1 (de) N-palmitoylethanolamid-enthaltende pharmazeutische zusammensetzungen und deren verwendung in der veterinärmedizin
DE60008400D1 (de) Triazolopyrimidinderivate
CY1109541T1 (el) Φαρμακευτικη συνταγοποιηση για την θεραπεια οστεοαρθριτιδας η οποια περιεχει κλοδρονικο οξυ και υαλουρονικο οξυ
DE50307423D1 (de) Kationische polymerisate und deren verwendung in kosmetischen formulierungen
GEP20074075B (en) Indazolamides with analgesic activity
DE60028593D1 (de) Perkutane absorptionsbeschleuniger für die elektroporation
DE60231385D1 (de) Formulierungen, die eingeschlossene wirkstoffe enthalten, und ihre verwendung
WO2005011565A3 (fr) Vernis a ongles a action antimycosique

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee